Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | KDM5A | P29375 | 3/20 | 0.44 |
| ▸ | PHF8 | Q9UPP1 | 3/20 | 0.44 |
| ▸ | KDM2A | Q9Y2K7 | 3/20 | 0.44 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.44 |
| ▸ | KDM4A | O75164 | 1/20 | 0.44 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | FKBP1A | P62942 | 4/20 | 0.40 |
| ▸ | CYSLTR2 | Q9NS75 | 1/20 | 0.40 |
| ▸ | CYSLTR1 | Q9Y271 | 1/20 | 0.40 |
| ▸ | NAAA | Q02083 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Butyric Acid SCHEMBL28983071 | 0.88 | LMNA (0.45) | LMNAKDM5APHF8KDM2AKDM4C | |
| SCHEMBL8896243 | 0.87 | EPHX1 (0.45) | LMNAEPHX1SMN1; SMN2NAAAHPGD | |
| SCHEMBL28720305 | 0.87 | EPHX1 (0.45) | LMNAEPHX1SMN1; SMN2NAAAHPGD | |
| SCHEMBL18439 | 0.87 | EPHX1 (0.45) | LMNAEPHX1SMN1; SMN2NAAAHPGD | |
| Hydrochloric Acid SCHEMBL28284486 | 0.85 | EPHX1 (0.44) | LMNAEPHX1SMN1; SMN2FKBP1ANAAA | |
| SCHEMBL8894777 | 0.85 | EPHX1 (0.42) | LMNAEPHX1SMN1; SMN2FKBP1ANAAA | |
| SCHEMBL6931991 | 0.83 | SMN1; SMN2 (0.56) | EPHX1SMN1; SMN2FKBP1ANAAACYP1A2 | |
| SCHEMBL19842292 | 0.83 | SMN1; SMN2 (0.56) | EPHX1SMN1; SMN2FKBP1ANAAACYP1A2 | |
| SCHEMBL225946 | 0.83 | KDM5A (0.57) | LMNAKDM5APHF8KDM2AKDM4C | |
| SCHEMBL9133016 | 0.83 | KDM5A (0.57) | LMNAKDM5APHF8KDM2AKDM4C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4695016-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2026-02-18 | — | — | EP | disclosed |
| CN-119584860-A | Comprising biodegradable microcapsule composition | 奇华顿股份有限公司 | 2025-03-07 | — | — | CN | disclosed |
| CN-119546194-A | Improvements in or relating to organic compounds | 奇华顿股份有限公司 | 2025-02-28 | — | — | CN | disclosed |
| CN-118974230-A | Fabric care compositions | 奇华顿股份有限公司 | 2024-11-15 | — | — | CN | disclosed |
| WO-2024213507-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2024-10-17 | — | — | WO | disclosed |
| EP-4446001-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2024-10-16 | — | — | EP | disclosed |
| CN-118369412-A | Solid composition | 奇华顿股份有限公司 | 2024-07-19 | — | — | CN | disclosed |
| CN-118251271-A | Improvements in or relating to organic compounds | 奇华顿股份有限公司 | 2024-06-25 | — | — | CN | disclosed |
| CN-118119691-A | Composition and method for producing the same | 奇华顿股份有限公司 | 2024-05-31 | — | — | CN | disclosed |
| US-20240173230-A1 | FRAGRANCE COMPOSITION | GIVAUDAN SA (CH) | 2024-05-30 | — | — | US | disclosed |
| CN-117794635-A | Improvements in or relating to organic compounds | 奇华顿股份有限公司 | 2024-03-29 | — | — | CN | disclosed |
| EP-4319715-A1 | FRAGRANCE COMPOSITION | Givaudan SA (CH) | 2024-02-14 | — | — | EP | disclosed |
| CN-117015593-A | Use of enzymes for improving fragrance deposition | 诺维信公司 | 2023-11-07 | — | — | CN | disclosed |
| CN-116457084-A | Improvements in or relating to organic compounds | 奇华顿股份有限公司 | 2023-07-18 | — | — | CN | disclosed |
| CN-115942990-A | Improvements in or relating to organic compounds | 奇华顿股份有限公司 | 2023-04-07 | — | — | CN | disclosed |
| WO-2022214636-A1 | FRAGRANCE COMPOSITION | GIVAUDAN SA (CH) | 2022-10-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240173230-A1 | FRAGRANCE COMPOSITION | FABP2, FABP5, FAAH2 | LMNA 4339/4885KDM5A 437/4885PHF8 930/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.